TSC1/TSC2 mutations will cause dysfunction of the complex, resulting in activation of the mTOR signaling pathway, thus inducing the occurrence of TSC-related benign tumors or hamartomas in multiple systems [4]. Here, TSC1 is linked to hamartoma.